Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kent

Showing results (971-980 of 1,017) with videos related to

Pageof 102
Sort By:
Infection and Immunity|October 30, 2024
Transiently boosting Vγ9+Vδ2+ γδ T cells early in Mtb coinfection of SIV-infected juvenile macaques does not improve Mtb host resistanceErica C Larson, Amy L Ellis, Mark A Rodgers, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
Transiently boosting Vγ9+Vδ2+ γδ T cells early in Mtb coinfection of SIV-infected juvenile macaques does not improve Mtb host resistanceErica C Larson, Amy L Ellis, Mark A Rodgers, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2020
Suboptimal SARS-CoV-2-specific CD8<sup>+</sup> T cell response associated with the prominent HLA-A*02:01 phenotypeJennifer R Habel, Thi H O Nguyen, Carolien E van de Sandt, et al.
Iscience|October 10, 2022
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2Phillip Pymm, Samuel J Redmond, Olan Dolezal, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2010
Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonistsBrian C Shook, Stefanie Rassnick, Devraj Chakravarty, et al.
Frontiers in Immunology|January 27, 2023
Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
Frontiers in Immunology|August 15, 2022
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
Science (New York, N.Y.)|January 11, 2020
Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cellsMarc Rigau, Simone Ostrouska, Thomas S Fulford, et al.
Clinical & Translational Immunology|March 8, 2021
Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody featuresLouise C Rowntree, Brendon Y Chua, Suellen Nicholson, et al.
Brain Injury|February 7, 2022
Advanced brain age in deployment-related traumatic brain injury: A LIMBIC-CENC neuroimaging studyEmily L Dennis, Brian A Taylor, Mary R Newsome, et al.
Pageof 102

Showing results (971-980 of 1,017) with videos related to

Sort By:
Pageof 102
Infection and Immunity|October 30, 2024
Transiently boosting Vγ9+Vδ2+ γδ T cells early in Mtb coinfection of SIV-infected juvenile macaques does not improve Mtb host resistanceErica C Larson, Amy L Ellis, Mark A Rodgers, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
Transiently boosting Vγ9+Vδ2+ γδ T cells early in Mtb coinfection of SIV-infected juvenile macaques does not improve Mtb host resistanceErica C Larson, Amy L Ellis, Mark A Rodgers, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2020
Suboptimal SARS-CoV-2-specific CD8<sup>+</sup> T cell response associated with the prominent HLA-A*02:01 phenotypeJennifer R Habel, Thi H O Nguyen, Carolien E van de Sandt, et al.
Iscience|October 10, 2022
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2Phillip Pymm, Samuel J Redmond, Olan Dolezal, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2010
Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonistsBrian C Shook, Stefanie Rassnick, Devraj Chakravarty, et al.
Frontiers in Immunology|January 27, 2023
Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
Frontiers in Immunology|August 15, 2022
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
Science (New York, N.Y.)|January 11, 2020
Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cellsMarc Rigau, Simone Ostrouska, Thomas S Fulford, et al.
Clinical & Translational Immunology|March 8, 2021
Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody featuresLouise C Rowntree, Brendon Y Chua, Suellen Nicholson, et al.
Brain Injury|February 7, 2022
Advanced brain age in deployment-related traumatic brain injury: A LIMBIC-CENC neuroimaging studyEmily L Dennis, Brian A Taylor, Mary R Newsome, et al.
Pageof 102